Will Bitcoin reclaim $65K despite ETF outflows? Check forecast
Bitcoin has reclaimed the $63,000 level after adding 2.5% to its value in the last 24 hours. However, the rally could be short-lived
Bitcoin
Bitcoin
Why Claude Mythos Preview is a wake-up call for Wall Street
Anthropic’s Claude Mythos Preview was not designed as a stock picker, a credit analyst, or a trading assistant. The model sits in a
Bitcoin
SpaceX IPO’s valuation battle has bulls aiming share at $165 while bears see $63
The long-awaited public debut of SpaceX has finally arrived, triggering one of the sharpest divisions among market experts in recent memory. The Elon
Business
US PPI rises by more than expected; annual producer price rise highest in 3 years
US annual wholesale inflation accelerated to its highest level in more than three years in May, though underlying price pressures remained relatively contained.
Business
ECB raises interest rates as Middle East conflict fuels inflation concerns
The European Central Bank raised interest rates on Thursday, a move that had been widely anticipated by markets, as policymakers sought to prevent
Business
Dow jumps 246 points as chip stocks rebound despite Iran tensions
US stocks opened higher on Thursday as investors returned to beaten-down technology shares following a sharp selloff, though gains were tempered by rising
Business
Oil and gas prices underpricing Hormuz risks warns ING
Energy markets are showing signs of complacency in the face of a major supply shock caused by the ongoing closure of the Strait
Business
Column: Wall Street’s AI-fueled surge is running into resistance
The US tech sector has had a torrid time of late. Ever since Broadcom issued some disappointing forward guidance, along with a solid,
Business
Crypto at the checkout: what America’s spending data reveals
The regulatory framework for crypto assets in the United States is finally coming of age, with the GENIUS Act having established a regulatory
Business
Nvidia teams up with Abridge to build AI model for healthcare: report
Nvidia is expanding its presence in healthcare artificial intelligence through a new partnership with medical technology startup Abridge, as competition intensifies among technology